Intercellular adhesion molecule-1 gene expression by glial cells: Differential mechanisms of inhibition by IL-10 and IL-6

P. Shrikant, E. Weber, T. Jilling, E. N. Benveniste

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

The central nervous system contains two major glial cell types, astrocytes and microglia, which function as immune effector cells within the central nervous system. We have been studying the ability of glial cells to express gene products involved in immune responsiveness, with an emphasis on expression of ICAM-1. We demonstrated previously that three proinflammatory cytokines, TNF-α, IL-1β, and IFN-γ, as well as IFN-γ plus LPS, can enhance ICAM-1 expression by primary rat astrocytes. In this study, we examined ICAM-1 expression by primary rat microglia and found that only IFN- γ and IFN-γ/LPS enhance ICAM-1 gene expression. These data indicate that ICAM-1 expression by astrocytes and microglia is enhanced differentially by various proinflammatory cytokines. We next examined the effect of two cytokines, IL-10 and IL-6, on ICAM-1 expression. IL-10 alone has no effect on ICAM-1 expression, but it inhibits the enhancement of ICAM-1 intracellular and membrane protein expression in both cell types, although it has no influence on ICAM-1 steady-state mRNA levels. These results suggest that IL- 10 affects ICAM-1 expression at the translational and/or post-translational level. IL-6 alone also had no effect on ICAM-1 expression in either astrocytes or microglia, but it inhibited induction of both ICAM-1 mRNA and protein expression in these cells. Inhibition of ICAM-1 mRNA steady-state levels by IL-6 was not the result of degradation of the ICAM-1 message, suggesting an effect at the transcriptional level. Thus, both IL-10 and IL-6 can inhibit ICAM-1 expression by glial cells, although they do so by contrasting mechanisms.

Original languageEnglish (US)
Pages (from-to)1489-1501
Number of pages13
JournalJournal of Immunology
Volume155
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Intercellular Adhesion Molecule-1
Neuroglia
Interleukin-10
Interleukin-6
Gene Expression
Microglia
Astrocytes
Cytokines
Messenger RNA
Central Nervous System
Intracellular Membranes
Interleukin-1
Membrane Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Intercellular adhesion molecule-1 gene expression by glial cells : Differential mechanisms of inhibition by IL-10 and IL-6. / Shrikant, P.; Weber, E.; Jilling, T.; Benveniste, E. N.

In: Journal of Immunology, Vol. 155, No. 3, 1995, p. 1489-1501.

Research output: Contribution to journalArticle

Shrikant, P. ; Weber, E. ; Jilling, T. ; Benveniste, E. N. / Intercellular adhesion molecule-1 gene expression by glial cells : Differential mechanisms of inhibition by IL-10 and IL-6. In: Journal of Immunology. 1995 ; Vol. 155, No. 3. pp. 1489-1501.
@article{ae483951c10543ae94c8cae464164903,
title = "Intercellular adhesion molecule-1 gene expression by glial cells: Differential mechanisms of inhibition by IL-10 and IL-6",
abstract = "The central nervous system contains two major glial cell types, astrocytes and microglia, which function as immune effector cells within the central nervous system. We have been studying the ability of glial cells to express gene products involved in immune responsiveness, with an emphasis on expression of ICAM-1. We demonstrated previously that three proinflammatory cytokines, TNF-α, IL-1β, and IFN-γ, as well as IFN-γ plus LPS, can enhance ICAM-1 expression by primary rat astrocytes. In this study, we examined ICAM-1 expression by primary rat microglia and found that only IFN- γ and IFN-γ/LPS enhance ICAM-1 gene expression. These data indicate that ICAM-1 expression by astrocytes and microglia is enhanced differentially by various proinflammatory cytokines. We next examined the effect of two cytokines, IL-10 and IL-6, on ICAM-1 expression. IL-10 alone has no effect on ICAM-1 expression, but it inhibits the enhancement of ICAM-1 intracellular and membrane protein expression in both cell types, although it has no influence on ICAM-1 steady-state mRNA levels. These results suggest that IL- 10 affects ICAM-1 expression at the translational and/or post-translational level. IL-6 alone also had no effect on ICAM-1 expression in either astrocytes or microglia, but it inhibited induction of both ICAM-1 mRNA and protein expression in these cells. Inhibition of ICAM-1 mRNA steady-state levels by IL-6 was not the result of degradation of the ICAM-1 message, suggesting an effect at the transcriptional level. Thus, both IL-10 and IL-6 can inhibit ICAM-1 expression by glial cells, although they do so by contrasting mechanisms.",
author = "P. Shrikant and E. Weber and T. Jilling and Benveniste, {E. N.}",
year = "1995",
language = "English (US)",
volume = "155",
pages = "1489--1501",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Intercellular adhesion molecule-1 gene expression by glial cells

T2 - Differential mechanisms of inhibition by IL-10 and IL-6

AU - Shrikant, P.

AU - Weber, E.

AU - Jilling, T.

AU - Benveniste, E. N.

PY - 1995

Y1 - 1995

N2 - The central nervous system contains two major glial cell types, astrocytes and microglia, which function as immune effector cells within the central nervous system. We have been studying the ability of glial cells to express gene products involved in immune responsiveness, with an emphasis on expression of ICAM-1. We demonstrated previously that three proinflammatory cytokines, TNF-α, IL-1β, and IFN-γ, as well as IFN-γ plus LPS, can enhance ICAM-1 expression by primary rat astrocytes. In this study, we examined ICAM-1 expression by primary rat microglia and found that only IFN- γ and IFN-γ/LPS enhance ICAM-1 gene expression. These data indicate that ICAM-1 expression by astrocytes and microglia is enhanced differentially by various proinflammatory cytokines. We next examined the effect of two cytokines, IL-10 and IL-6, on ICAM-1 expression. IL-10 alone has no effect on ICAM-1 expression, but it inhibits the enhancement of ICAM-1 intracellular and membrane protein expression in both cell types, although it has no influence on ICAM-1 steady-state mRNA levels. These results suggest that IL- 10 affects ICAM-1 expression at the translational and/or post-translational level. IL-6 alone also had no effect on ICAM-1 expression in either astrocytes or microglia, but it inhibited induction of both ICAM-1 mRNA and protein expression in these cells. Inhibition of ICAM-1 mRNA steady-state levels by IL-6 was not the result of degradation of the ICAM-1 message, suggesting an effect at the transcriptional level. Thus, both IL-10 and IL-6 can inhibit ICAM-1 expression by glial cells, although they do so by contrasting mechanisms.

AB - The central nervous system contains two major glial cell types, astrocytes and microglia, which function as immune effector cells within the central nervous system. We have been studying the ability of glial cells to express gene products involved in immune responsiveness, with an emphasis on expression of ICAM-1. We demonstrated previously that three proinflammatory cytokines, TNF-α, IL-1β, and IFN-γ, as well as IFN-γ plus LPS, can enhance ICAM-1 expression by primary rat astrocytes. In this study, we examined ICAM-1 expression by primary rat microglia and found that only IFN- γ and IFN-γ/LPS enhance ICAM-1 gene expression. These data indicate that ICAM-1 expression by astrocytes and microglia is enhanced differentially by various proinflammatory cytokines. We next examined the effect of two cytokines, IL-10 and IL-6, on ICAM-1 expression. IL-10 alone has no effect on ICAM-1 expression, but it inhibits the enhancement of ICAM-1 intracellular and membrane protein expression in both cell types, although it has no influence on ICAM-1 steady-state mRNA levels. These results suggest that IL- 10 affects ICAM-1 expression at the translational and/or post-translational level. IL-6 alone also had no effect on ICAM-1 expression in either astrocytes or microglia, but it inhibited induction of both ICAM-1 mRNA and protein expression in these cells. Inhibition of ICAM-1 mRNA steady-state levels by IL-6 was not the result of degradation of the ICAM-1 message, suggesting an effect at the transcriptional level. Thus, both IL-10 and IL-6 can inhibit ICAM-1 expression by glial cells, although they do so by contrasting mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0029166306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029166306&partnerID=8YFLogxK

M3 - Article

C2 - 7636212

AN - SCOPUS:0029166306

VL - 155

SP - 1489

EP - 1501

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -